AGLagilon health, inc.
$82.66+185% 1Y
$82.66
$7.9152 weeks$129.35
The financials
agilon health, inc. by the numbers
agilon health, inc. (AGL) reported revenue of $1.49B in Q2 2026 (quarter ended Jun 30, 2026), up 7.2% from the same quarter a year earlier. That came with net income of $18M (1.2% of revenue). For the full year FY2025, revenue was $5.93B (−2.1% year on year) and net income −$391M. Its largest product in Q2 2026 was Medical Services at $1.49B, 100% of the disclosed total, well ahead of Other Operating at 0.1%. The next results filing is expected around Nov 3, 2026, the same week as a year ago.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Revenue | $1.49B | $1.39B | +7.2% |
| Operating income | $12M | −$116M | to a profit |
| Net income | $18M | −$104M | to a profit |
| Diluted EPS | $1.04 | −$6.31 | to a profit |
| Product | Revenue | Share |
|---|---|---|
| Medical Services | $1.49B | 100% |
| Other Operating | $1.8M | 0.1% |
Business segments
Revenue split by product segment, from SEC XBRL filings.
Latest period: Jun 2026Total $1.49B (+5.2%)
Medical Services grew +7.2% year on yearOther Operating -38% year on year
Segment Latestquarter on quarteryear on year
- Medical Services$1.49B$1.49Bquarter on quarter +5.2%year on year +7.2%+5.2%+7.2%
- Other Operating$1.8M$1.8Mquarter on quarter -4.7%year on year -38%-4.7%-38%